Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents

Ruo-Jun Man; Nasreen Jeelani; Chongchen Zhou; Yu-Shun Yang

doi:10.2174/1871520620666200516150345

Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents

Ruo-Jun Man
, Nasreen Jeelani
, Chongchen Zhou
, Yu-Shun Yang

Veröffentlichungen: Beitrag in Fachzeitschrift › Artikel › Peer Reviewed

Originalsprache	Englisch
Seiten (von - bis)	825-838
Seitenumfang	14
Fachzeitschrift	Anti-Cancer Agents in Medicinal Chemistry
Jahrgang	21
Ausgabenummer	7
DOIs	https://doi.org/10.2174/1871520620666200516150345
Publikationsstatus	Veröffentlicht - 2021
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

ÖFOS 2012

305905 Medizinische Informatik

Zugriff auf Dokument

10.2174/1871520620666200516150345

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Zitationsweisen

@article{a30120c2b7554a59a2aa85ec95107fd7,

title = "Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents",

keywords = "Anti-cancer agents, quinoline derivatives, marketed drugs, clinical trials, molecular targets, major mechanisms, TYROSINE KINASE INHIBITOR, TOPOISOMERASE-I INHIBITOR, DUAL PI3K/MTOR INHIBITOR, GROWTH-FACTOR, DNA TOPOISOMERASES, HEPATOCELLULAR-CARCINOMA, LIPOSOMAL FORMULATION, MOLECULAR-MECHANISMS, SELECTIVE ACTIVATION, CAMPTOTHECIN ANALOG, Major mechanisms, Clinical trials, Quinoline derivatives, Marketed drugs, Molecular targets",

author = "Ruo-Jun Man and Nasreen Jeelani and Chongchen Zhou and Yu-Shun Yang",

note = "Publisher Copyright: {\textcopyright} 2021 Bentham Science Publishers.",

year = "2021",

doi = "10.2174/1871520620666200516150345",

language = "English",

volume = "21",

pages = "825--838",

journal = "Anti-Cancer Agents in Medicinal Chemistry",

issn = "1871-5206",

publisher = "BENTHAM SCIENCE PUBL LTD",

number = "7",

}

TY - JOUR

T1 - Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents

AU - Man, Ruo-Jun

AU - Jeelani, Nasreen

AU - Zhou, Chongchen

AU - Yang, Yu-Shun

PY - 2021

Y1 - 2021

KW - Anti-cancer agents

KW - quinoline derivatives

KW - marketed drugs

KW - clinical trials

KW - molecular targets

KW - major mechanisms

KW - TYROSINE KINASE INHIBITOR

KW - TOPOISOMERASE-I INHIBITOR

KW - DUAL PI3K/MTOR INHIBITOR

KW - GROWTH-FACTOR

KW - DNA TOPOISOMERASES

KW - HEPATOCELLULAR-CARCINOMA

KW - LIPOSOMAL FORMULATION

KW - MOLECULAR-MECHANISMS

KW - SELECTIVE ACTIVATION

KW - CAMPTOTHECIN ANALOG

KW - Major mechanisms

KW - Clinical trials

KW - Quinoline derivatives

KW - Marketed drugs

KW - Molecular targets

UR - https://www.scopus.com/pages/publications/85100670070

U2 - 10.2174/1871520620666200516150345

DO - 10.2174/1871520620666200516150345

M3 - Article

SN - 1871-5206

VL - 21

SP - 825

EP - 838

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

IS - 7

ER -

Recent progress in the development of quinoline derivatives for the exploitation of anti-cancer agents

UN SDGs

ÖFOS 2012

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Zitationsweisen